Free Post Earnings Research Report: MKS Instruments Quarterly Revenue Surged 26%; EPS Soared 70%
Stock Monitor: Coherent Post Earnings Reporting
LONDON, UK / ACCESSWIRE / February 16, 2018 / Active-Investors.com has just released a free earnings report on MKS Instruments, Inc. (NASDAQ: MKSI). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=MKSI. MKS Instruments reported its fourth quarter and fiscal 2017 operating and financial results on January 31, 2018. The maker of analysis and processing equipment for semiconductor companies outperformed top- and bottom-line expectations and provided guidance for the upcoming quarter. Register today and get access to over 1,000 Free Research Reports by joining our site below:
www.active-investors.com/registration-sg
Active-Investors.com is currently working on the research report for Coherent, Inc. (NASDAQ: COHR), which also belongs to the Technology sector as the Company MKS Instruments. Do not miss out and become a member today for free to access this upcoming report at:
www.active-investors.com/registration-sg/?symbol=COHR
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, MKS Instruments most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:
www.active-investors.com/registration-sg/?symbol=MKSI
Earnings Highlights and Summary
MKS Instruments’ sales were $512 million for the three months ended December 31, 2017, reflecting an increase of 26% from sales of $405 million in Q4 2016. The Company’s reported numbers exceeded analysts’ estimates of $500.3 million.
For FY17, MKS Instruments’ sales were a record $1.92 billion, reflecting an increase of 30% from sales of $1.47 billion in FY16 on a pro-forma basis, driven by strong sales to both semiconductor customers as well as customers in thin film manufacturing, industrial manufacturing, and health and life sciences.
During Q4 2017, MKS Instruments’ net income was $77.6 million, or $1.41 per diluted share, compared to net income of $45.5 million, or $0.83 per diluted share, in Q4 2016. The Company’s non-GAAP net earnings, which exclude special charges and credits, were $94.6 million, or $1.71 per diluted share, in the reported quarter compared to $57.2 million, or $1.05 per diluted share, in the year-earlier same quarter. MKS Instruments’ earnings beat Wall Street’s estimates of $1.62 per share.
For FY17, MKS Instruments reported $339.13 million, or $6.16 per diluted share, compared to net income of $104.81 million, or $1.94 per diluted share, in FY16. The Company’s non-GAAP net earnings totaled $328.28 million, or $5.96 per diluted share, in FY17 compared to $164.02 million, or $3.03 per diluted share, in FY16.
Segment Details
During Q4 2017, MKS Instruments’ sales to semiconductor customers were $284 million, reflecting a growth of 1% on q-o-q basis, and sales to advanced markets were $228 million in the quarter, reflecting an increase of 11% sequentially driven largely by strong growth from the Company’s Light and Motion Division.
For Q4 2017, MKS Instruments’ sales in the Vacuum and Analysis segment, set a quarterly record of $311 million, driven by very strong sales to semiconductor customers. The Company’s sales in the Light and Motion segment, the historic Newport business, also set a quarterly record of $201 million.
Cash Matters
As of December 31, 2017, MKS Instruments had $543 million in cash and short-term investments and $398 million outstanding under its Term Loan. During Q4 2017, the Company made voluntary term loan repayment of $50 million and paid a dividend of $9.8 million or $0.18 per diluted share.
Outlook
For the first quarter fiscal 2018, MKS Instruments is forecasting sales in the range of $510 million to $550 million. The Company is projecting GAAP net income for the upcoming quarter to be in the band of $1.68 to $1.95 per diluted share and non-GAAP net earnings in the range of $1.86 to $2.12 per diluted share.
Updated Operating Model
MKS Instruments published an updated operating model, which reflects an illustrative revenue level of $2.2 billion, improvements in gross margin, lower interest expense, and the expected impact of the 2017 Tax Cut and Jobs Act in FY18. As a result of these improvements, non-GAAP earnings for FY18 increased by 33% to $8.55 per share compared to $6.42 per share in the prior operating model published in October 2017.
Stock Performance Snapshot
February 15, 2018 – At Thursday’s closing bell, MKS Instruments’ stock climbed 3.30%, ending the trading session at $111.10.
Volume traded for the day: 664.36 thousand shares.
Stock performance in the last month – up 7.55%; previous three-month period – up 7.45%; past twelve-month period – up 64.11%; and year-to-date – up 17.57%
After yesterday’s close, MKS Instruments’ market cap was at $6.03 billion.
Price to Earnings (P/E) ratio was at 18.04.
The stock has a dividend yield of 0.65%.
The stock is part of the Technology sector, categorized under the Scientific & Technical Instruments industry. This sector was up 1.5% at the end of the session.
Active-Investors:
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active-Investors
ReleaseID: 489483